Inventor · disambiguated record
Fabien Schweighoffer
Also filed as: SCHWEIGHOFFER FABIEN · SCHWEIGHOFFER FABIEN JACQUES
16 granted patents·21 pending applications·240 citations·filing 1993–2012
94Inventor score
Files withEXONHIT THERAPEUTICS SA15RHONE POULENC RORER SA4AVENTIS PHARMA SA3SCHWEIGHOFFER FABIEN3DESIRE LAURENT2
Top patents by PatentIndex Score
37 records- 0176US9278943B2Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compoundsLEBLOND BERTRAND·Filed 2012·Granted Mar 8, 2016·1 cites·12 claims
- 0276US6372432B1Methods and composition for the detection of pathologic eventsEXONHIT THERAPEUTICS SA·Filed 1999·Granted Apr 16, 2002·46 cites·11 claims
- 0375US8003375B2Qualitative differential screeningEXONHIT THERAPEUTICS SA·Filed 2009·Granted Aug 23, 2011·0 cites·24 claims
- 0475US5886150APeptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereofRHONE POULENC RORER SA·Filed 1995·Granted Mar 23, 1999·41 cites·7 claims
- 0570US6251590B1Differential Qualitative screeningEXONHIT THERAPEUTICS SA·Filed 1998·Granted Jun 26, 2001·39 cites·25 claims
- 0669US2010144555A1Qualitative differential screeningEXONHIT THERAPEUTICS·Filed 2009·Application pending·0 cites
- 0769US2009264301A1Methods utilizing differential splicing events in blood cells for the detection of pathological eventsEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 0868US7514432B2Compounds and methods of treating cell proliferative diseases, retinopathies and arthritisEXONHIT THERAPEUTICS SA·Filed 2004·Granted Apr 7, 2009·6 cites·15 claims
- 0968US6881571B1Qualitative differential screeningEXONHIT THERAPEUTICS SA·Filed 1999·Granted Apr 19, 2005·27 cites·22 claims
- 1068US5656595APeptides having GDP exchange factor activity, nucleic acid sequences coding for these peptides, preparation and useRHONE POULENC RORER SA·Filed 1993·Granted Aug 12, 1997·24 cites·9 claims
- 1165US5831048AGrb3-3 cDNA and polypeptidesRHONE POULENC RORER SA·Filed 1994·Granted Nov 3, 1998·15 cites·17 claims
- 1265US2004191828A1Qualitative differential screeningFiled 2004·Application pending·0 cites
- 1359US2009093471A1Methods of Treating Nervous DisordersDESIRE LAURENT·Filed 2006·Application pending·0 cites
- 1458US6855736B2Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2001·Granted Feb 15, 2005·3 cites·7 claims
- 1558US2007027146A1Methods of treating nervous disordersEXONHIT THERAPEUTICS SA·Filed 2005·Application pending·0 cites
- 1658US2003165931A1Qualitative differential screeningFiled 2002·Application pending·0 cites
- 1757US6159947AAnti-RAS intracellular binding proteins and use thereofAVENTIS PHARMA SA·Filed 1994·Granted Dec 12, 2000·14 cites·14 claims
- 1857US2005043319A1Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2004·Application pending·0 cites
- 1955US2010204251A1Molecular target of neurotoxicityEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 2053US2009216014A1Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritisEXONHIT THERAPEUTICS SA·Filed 2009·Application pending·0 cites
- 2153US2003059788A1Genetic markers of toxicity, preparation and uses thereofFiled 2001·Application pending·0 cites
- 2251US6544948B1ΔP62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancerAVENTIS PHARMA SA·Filed 1996·Granted Apr 8, 2003·9 cites·6 claims
- 2348US6509153B1Genetic markers of toxicity preparation and usesEXONHIT THERAPEUTICS SA·Filed 1999·Granted Jan 21, 2003·8 cites·25 claims
- 2448US2009269744A1Cancer detection methodEXONHIT THERAPEUTICS SA·Filed 2006·Application pending·0 cites
- 2545US2010055682A1Procedure and methods for detecting alzheimers's diseaseSCHWEIGHOFFER FABIEN·Filed 2007·Application pending·0 cites
- 2645US2009317842A1Methods and Tools for The Therapy of Neurodegenerative PathologiesEXONHIT THERAPEUTICS SA·Filed 2007·Application pending·0 cites
- 2744US7872015B2Methods involving PDE4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologiesEXONHIT THERAPEUTICS SA·Filed 2004·Granted Jan 18, 2011·0 cites·3 claims
- 2843US2009118282A1Compounds and methods for treatment of amyloid-beta-peptide related disordersLEBLOND BERTRAND·Filed 2006·Application pending·0 cites
- 2941US2003032032A1Early pre-symptomatic prion diagnostic blood test for encephalopathiesFiled 2002·Application pending·0 cites
- 3040US6180362B1Peptides which inhibit ras protein activity, their preparation and useRHONE POULENC RORER SA·Filed 1993·Granted Jan 30, 2001·7 cites·44 claims
- 3140US2008153758A1Compounds Which Inhibits Protein Prenylation E.G. Geranylgeransferse or Farnesyltransferase Inhibitors for Treating Parkinson's DiseaseSCHWEIGHOFFER FABIEN·Filed 2005·Application pending·0 cites
- 3240US2012202846A1Molecular target of neurotoxicityAIT IKHLEF ALI·Filed 2012·Application pending·0 cites
- 3337US2009285820A1Methods of Treating Degenerative Disorders With Rac 1B InhibitorDESIRE LAURENT·Filed 2007·Application pending·0 cites
- 3436US2004219552A1Novel molecular target for neurotoxicityFiled 2001·Application pending·0 cites
- 3535US2005009030A1Histone deacetylase: novel molecular target of neurotoxicityFiled 2003·Application pending·0 cites
- 3635US2006142326A1Use of pyrazolopyridines for the treatment of cognitive deficitsSCHWEIGHOFFER FABIEN·Filed 2004·Application pending·0 cites
- 3731USRE37952EGrb3-3 cDNA and polypeptidesAVENTIS PHARMA SA·Filed 1994·Granted Dec 31, 2002·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Fabien Schweighoffer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →